To facilitate quantitative immunohistochemical studies, FFPE sections of breast cancer cells transfected with either non-targeting control siRNA or previously validated CDK18 siRNA [10] were used to optimise IHC staining conditions (Supplementary Figure 1A and 1B). This evidence concerns the gene CDK18 and breast cancer.